Hepatic porphyrias;Les porphyries hepatiques

Revue de Medecine Interne

Volumn 20, Issue 4, 1999, Pages 333-340

  Nordmann, Y ^a   Puy, H ^a   Deybach, J C ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

Enzyme; Heme; Porphyria

Indexed keywords

HEMATIN; PORPHYRIN; CHARCOAL; CHLOROQUINE; CHLORPROMAZINE; DRUG DERIVATIVE; GONADORELIN; HEMIN; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; PETHIDINE;

DISEASE PREDISPOSITION; ENZYME DEFICIENCY; GENE ISOLATION; GENE LOCATION; GENE MUTATION; HEMOCHROMATOSIS; HEPATIC PORPHYRIA; HEPATITIS C VIRUS; NEUROPATHY; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; ACUTE INTERMITTENT PORPHYRIA; ADULT; CHILD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; NEWBORN; PHLEBOTOMY; PRESCHOOL CHILD;

ADULT; ANALGESICS, OPIOID; ANTIPSYCHOTIC AGENTS; CHARCOAL; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CHLORPROMAZINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HEMIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEPERIDINE; MIDDLE AGED; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIAS, HEPATIC;

EID: 0032696460     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)83073-2     Document Type: Review

References (22)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The Porphyrias. Scriver CR. 6th ed. The metabolic basis of inherited diseases. 1995;2103-2159 McGraw Hill, New York.
2. Bonkowsky HL, Schady W. Neurological manifestations of acute porphyria. Semin Liver Dis. 2:1982;108-124.
3. Grandchamp B, Phung LN, Nordmann Y. Homozygous case of hereditary coproporphyria. Lancet. i:1977;1348-1349.
4. Nordmann Y, Grandchamp B, de Verneuil H, Phung NL, Cartigny B, Fontaine G. Harderoporphyria: a variant hereditary coproporphyria. J Clin Invest. 72:1983;1139-1149.
5. Lamoril J, Martasek P, Deybach JC, Da Silva V, Grandchamp B, Nordmann Y. A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. Hum Mol Genet. 4:1995;275-278.
6. Roberts AG, Puy H, Dailey TA, Morgan RR, Whatley SD, Dailey HA, et al. Molecular characterization of homozygous variegate porphyria. Hum Mol Genet. 1998.
7. Llewellyn DH, Smyth SJ, Elder GH, Hutchesson AC, Rattenbury JM, Smith MF. Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transition in the same codon of the porphobilinogen deaminase gene. Hum Genet. 89:1992;97-98.
8. Solis C, Xu NM, Bermejo AM, Smith MF, Astrin KH, Desnick RJ. Homozygous dominant acute intermittent porphyria: clinical spectrum and biochemical/genotypic correlations. Scand J Clin Lab Invest. 55:1995;133.
9. Nordmann Y, Puy H, Da Silva V, Simonin S, Robréau AM, Bonaiti C, et al. Acute intermittent porphyria: prevalence of mutations in the PBG deaminase gene in blood donors in France. J Intern Med. 242:1997;213-217.
10. Puy H, Deybach JC, Lamoril J, Robréau AM, Da Silva V, Gouya L, et al. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet. 60:1997;1373-1383.
11. Doss M, Von Tiepermann R, Schneider J, Schmid H. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr. 57:1979;1123-1127.
12. Plewinska M, Thunell S, Holmberg L, Wetmur JG, Desnick RJ. Delta aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote. Am J Hum Genet. 49:1991;167-174.
13. Mustajoki P, Nordmann Y. Early administration of heme-arginate for acute porphyric attacks. Arch Internal Med. 153:1993;2004-2009.
14. Wyman JF, Gollan JL, Settle W, Farrell GC, Correia MA. Incorporation of haemogloblin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450. Biochem J. 238:1986;837-846.
15. Anderson KE, Spitz IM, Sassa S, Bardin W, Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long acting agonist of luteiniscing hormone releasing hormone. N Engl J Med. 311:1984;643-645.
16. De Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea tarda: two different diseases. Hum Genet. 44:1978;145-151.
17. Lamoril J, Andant C, Puy H, Gouya L, Pawlotsky JM, Da Silva V, et al. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology. 27:1998;848-852.
18. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
19. Roberts AG, Elder GH, Newcombe RG, Desalamanca RE, Munoz JJ. Heterogeneity of familial porphyria cutanea tarda. J Med Genet. 10:1988;669-676.
20. Elder GH, Smith SG, Herrero C, Mascaro J, Lecha JM, Muniesca AM, et al. Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect of homozygous porphyria cutanea tarda. Lancet. i:1981;916-919.
21. 281→Glu) in a case of porphyria. Science. 324:1986;232-234.
22. Grandchamp B, Puy H, Lamoril J, Deybach JC, Nordmann Y. Molecular pathogenesis of hepatic acute porphyrias. J Gastroenterol Hepatol. 11:1996;1046-1052.